PROCEPT BioRobotics Corporation Stock
Equities
PRCT
US74276L1052
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.74 USD | +1.86% | +18.09% | +47.32% |
Financials (USD)
Sales 2024 * | 213M | Sales 2025 * | 299M | Capitalization | 3.17B |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -71M | EV / Sales 2024 * | 14.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.6 x |
P/E ratio 2024 * |
-31.2
x | P/E ratio 2025 * |
-44.2
x | Employees | 626 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.43% |
Latest transcript on PROCEPT BioRobotics Corporation
1 day | +1.86% | ||
1 week | +18.09% | ||
Current month | +16.53% | ||
1 month | +32.60% | ||
3 months | +28.87% | ||
6 months | +89.33% | ||
Current year | +47.32% |
Managers | Title | Age | Since |
---|---|---|---|
Reza Zadno
CEO | Chief Executive Officer | 69 | 20-02-05 |
Kevin Waters
DFI | Director of Finance/CFO | 46 | - |
Barry Templin
CTO | Chief Tech/Sci/R&D Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frederic Moll
CHM | Chairman | 72 | 11-07-31 |
Taylor Harris
BRD | Director/Board Member | 48 | 20-12-16 |
Reza Zadno
CEO | Chief Executive Officer | 69 | 20-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.60% | 16 M€ | -5.09% | ||
0.05% | 237 M€ | +0.55% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 61.74 | +1.86% | 1,020,737 |
24-05-01 | 60.61 | +14.40% | 2,129,587 |
24-04-30 | 52.98 | +1.79% | 875,721 |
24-04-29 | 52.05 | +0.42% | 593,649 |
24-04-26 | 51.83 | -0.86% | 586,484 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.32% | 3.12B | |
-3.77% | 184B | |
-1.77% | 107B | |
-1.43% | 67.52B | |
+2.06% | 50.06B | |
+9.43% | 45.67B | |
+3.40% | 41B | |
+3.04% | 26.73B | |
+4.64% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- PRCT Stock